Plougmann Vingtoft Blocks Inventors' Chemo Response IP

By Hanna Vioque ( November 7, 2025, 7:09 PM GMT) -- IP consulting firm Plougmann Vingtoft has convinced European appellate officials to nix a group of inventors' patented method to determine if a cancer patient is responsive to chemotherapy. ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections